Abhijit N. Shirke

Abhijit N. Shirke

Auto-generated profile, based on publicly available information

Abhijit N. Shirke

Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2018 in Biochemistry
Verified
Journal Article
Closed access
ASAbhijit N. Shirke
Abhijit N. Shirke
CWChristine White
Christine White
JEJacob A. Englaender
Jacob A. Englaender
AZAllison Zwarycz
Allison Zwarycz
GBGlenn L. Butterfoss
Glenn L. Butterfoss
Richard A. GrossRichard A. Gross
Richard A. Gross

5 July 2017 in mBio
Verified
Journal Article
Open access
PDF file
JJJ. Andrew Jones
J. Andrew Jones
VVVictoria R. Vernacchio
Victoria R. Vernacchio
SCShannon M. Collins
Shannon M. Collins
ASAbhijit N. Shirke
Abhijit N. Shirke
YXYu Xiu
Yu Xiu
Mattheos KoffasMattheos Koffas
Mattheos Koffas
Fermentation-based chemical production strategies provide a feasible route for the rapid, safe, and sustainable production of a wide variety of important chemical products, ranging from fuels to pharmaceuticals. These strategies have yet to find wide industrial utilization due to their inability to economically compete with traditional extraction and chemical production methods. Here, we engineer for the first time the complex microbial biosynthesis of an anthocyanin plant natural product, starting from sugar. This was accomplished through the development of a synthetic, 4-strain Escherichia coli polyculture collectively expressing 15 exogenous or modified pathway enzymes from diverse plants and other microbes. This synthetic consortium-based approach enables the functional expression and connection of lengthy pathways while effectively managing the accompanying metabolic burden. The de novo production of specific anthocyanin molecules, such as calistephin, has been an elusive metabolic engineering target for over a decade. The utilization of our polyculture strategy affords milligram-per-liter production titers. This study also lays the groundwork for significant advances in strain and process design toward the development of cost-competitive biochemical production hosts through nontraditional methodologies. IMPORTANCE To efficiently express active extensive recombinant pathways with high flux in microbial hosts requires careful balance and allocation of metabolic resources such as ATP, reducing equivalents, and malonyl coenzyme A (malonyl-CoA), as well as various other pathway-dependent cofactors and precursors. To address this issue, we report the design, characterization, and implementation of the first synthetic 4-strain polyculture. Division of the overexpression of 15 enzymes and transcription factors over 4 independent strain modules allowed for the division of metabolic burden and for independent strain optimization for module-specific metabolite needs. This study represents the most complex synthetic consortia constructed to date for metabolic engineering applications and provides a new paradigm in metabolic engineering for the reconstitution of extensive metabolic pathways in nonnative hosts.

11 June 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JJJ. Andrew Jones
J. Andrew Jones
VVVictoria R. Vernacchio
Victoria R. Vernacchio
DLDaniel M. Lachance
Daniel M. Lachance
MLMatthew Lebovich
Matthew Lebovich
LFLi Fu
Li Fu
Mattheos KoffasMattheos Koffas
Mattheos Koffas
The ability to fine tune gene expression has created the field of metabolic pathway optimization and balancing where a variety of factors affecting flux balance are carefully modulated to improve product titers, yields and productivity. Using a library of isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible mutant T7 promoters of varied strength a combinatorial method was developed for transcriptional balancing of the violacein pathway. Violacein biosynthesis involves a complex five-gene pathway that is an excellent model for exploratory metabolic engineering efforts into pathway regulation and control due to many colorful intermediates and side products allowing for easy analysis and strain comparison. Upon screening approximately 4% of the total initial library, several high-titer mutants were discovered that resulted in up to a 63-fold improvement over the control strain. With further fermentation optimization, titers were improved to 1829 ± 46 mg/L; a 2.6-fold improvement in titer and a 30-fold improvement in productivity from previous literature reports.

2 November 2015 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
ASAbhijit N. Shirke
Abhijit N. Shirke
DBDanielle Basore
Danielle Basore
GBGlenn L. Butterfoss
Glenn L. Butterfoss
RBRichard Bonneau
Richard Bonneau
CBChristopher Bystroff
Christopher Bystroff
Richard A. GrossRichard A. Gross
Richard A. Gross

1 September 2018 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
An SuAn Su
An Su
ASAbhijit Shirke
Abhijit Shirke
JBJoshua Baik
Joshua Baik
YZYi Zou
Yi Zou
Richard A. GrossRichard A. Gross
Richard A. Gross

18 July 2016 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
ASAbhijit N. Shirke
Abhijit N. Shirke
An SuAn Su
An Su
JJJ. Andrew Jones
J. Andrew Jones
GBGlenn L. Butterfoss
Glenn L. Butterfoss
MKMattheos A.G. Koffas
Mattheos A.G. Koffas
Richard A. GrossRichard A. Gross
Richard A. Gross